These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10352367)

  • 1. Transfer of genetically engineered cells to the glomerulus.
    Kitamura M
    Exp Nephrol; 1999; 7(3):259-66. PubMed ID: 10352367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transfer of genetically engineered cells.
    Kitamura M
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S154-8. PubMed ID: 11065349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo transfer of engineered macrophages into the glomerulus: endogenous TGF-beta-mediated defense against macrophage-induced glomerular cell activation.
    Sütö TS; Fine LG; Shimizu F; Kitamura M
    J Immunol; 1997 Sep; 159(5):2476-83. PubMed ID: 9278341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery into the renal glomerulus by transfer of genetically engineered, autologous mesangial cells.
    Kitamura M; Burton S; Yokoo T; Fine LG
    Exp Nephrol; 1996; 4(1):56-9. PubMed ID: 8788601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene delivery into rat glomerulus using a mesangial cell vector.
    Kim HJ; Kim SI; Yun IJ; Kwak JH; Yu SH
    Mol Cells; 2000 Dec; 10(6):662-8. PubMed ID: 11211871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of a mutated gene encoding active transforming growth factor-beta 1 suppresses mitogenesis and IL-1 response in the glomerulus.
    Kitamura M; Burton S; English J; Kawachi H; Fine LG
    Kidney Int; 1995 Dec; 48(6):1747-57. PubMed ID: 8587235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus.
    Kitamura M
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7387-91. PubMed ID: 8693003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive transfer of nuclear factor-kappaB-inactive macrophages to the glomerulus.
    Kitamura M
    Kidney Int; 2000 Feb; 57(2):709-16. PubMed ID: 10652050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated gene transfer to renal glomeruli in rodents.
    Ye X; Jerebtsova M; Liu XH; Li Z; Ray PE
    Kidney Int; 2002 Jan; 61(1 Suppl):S16-23. PubMed ID: 11841607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo.
    Kitamura M; Taylor S; Unwin R; Burton S; Shimizu F; Fine LG
    J Clin Invest; 1994 Aug; 94(2):497-505. PubMed ID: 8040302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsphere-adenoviral complexes target and transduce the glomerulus in vivo.
    Nahman NS; Sferra TJ; Kronenberger J; Urban KE; Troike AE; Johnson A; Holycross BJ; Nuovo GJ; Sedmak DD
    Kidney Int; 2000 Oct; 58(4):1500-10. PubMed ID: 11012885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome.
    Heikkila P; Parpala T; Lukkarinen O; Weber M; Tryggvason K
    Gene Ther; 1996 Jan; 3(1):21-7. PubMed ID: 8929908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of genetically modified macrophages elucidated TGF-beta-mediated 'self-defence' of the glomerulus against local action of macrophages.
    Kitamura M
    Nephrol Dial Transplant; 1999; 14 Suppl 1():35-8. PubMed ID: 10048446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1 as an endogenous defender against macrophage-triggered stromelysin gene expression in the glomerulus.
    Kitamura M
    J Immunol; 1998 May; 160(10):5163-8. PubMed ID: 9590269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer of interleukin-1 receptor antagonist into the renal glomerulus via a mesangial cell vector.
    Yokoo T; Kitamura M
    Biochem Biophys Res Commun; 1996 Sep; 226(3):883-8. PubMed ID: 8831705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular hypertension and progressive renal disease: the interplay of mesangial cell stretch, cytokine formation and extracellular matrix synthesis.
    Cortes P; Riser B; Narins RG
    Contrib Nephrol; 1996; 118():229-33. PubMed ID: 8744062
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfer of genetically engineered macrophages into the glomerulus.
    Kitamura M; Sütö TS
    Kidney Int; 1997 Apr; 51(4):1274-9. PubMed ID: 9083297
    [No Abstract]   [Full Text] [Related]  

  • 18. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
    Huijun W; Long C; Zhigang Z; Feng J; Muyi G
    Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular cells in vitro versus the glomerulus in vivo.
    Floege J; Radeke HR; Johnson RJ
    Kidney Int; 1994 Feb; 45(2):360-8. PubMed ID: 8164420
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting genetically modified macrophages to the glomerulus.
    Wilson HM; Kluth DC
    Nephron Exp Nephrol; 2003; 94(4):e113-8. PubMed ID: 12972709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.